Related Experiment Videos
Changes in pulmonary circulation in severe bronchopulmonary dysplasia
A Bush1, C M Busst, W B Knight
1Brompton Hospital, London.
Archives of Disease in Childhood
|July 1, 1990
Summary
Severe bronchopulmonary dysplasia is linked to high pulmonary vascular resistance and shunting. Pulmonary vasodilators, not oxygen, may improve outcomes in these patients.
Area of Science:
- Pediatric Pulmonology
- Cardiovascular Physiology
Background:
- Bronchopulmonary dysplasia (BPD) is a chronic lung disease in infants.
- Severe BPD often involves complex cardiopulmonary complications.
Purpose of the Study:
- To investigate the cardiopulmonary hemodynamics in infants with severe BPD.
- To assess the effects of epoprostenol and oxygen on pulmonary vascular resistance.
- To explore potential prognostic markers and therapeutic strategies.
Main Methods:
- Cardiac catheterization in eight patients with severe BPD.
- Measurement of pulmonary vascular resistance and intrapulmonary shunts.
- Assessment of response to epoprostenol (prostacyclin) and 100% oxygen.
- Morphometric analysis of lung tissue in three cases.
Main Results:
- Seven of eight patients had elevated pulmonary vascular resistance (mean 8.9 mm Hg.l-1 min.m2).
- All patients exhibited raised intrapulmonary shunts (mean 25.6%).
- Epoprostenol significantly reduced pulmonary vascular resistance; 100% oxygen did not.
- Morphometry revealed airway muscle thickening, reduced alveoli, and pulmonary artery medial hypertrophy.
Conclusions:
- High pulmonary vascular resistance and shunting are characteristic of severe BPD.
- Pulmonary vasodilators, such as epoprostenol, may be beneficial.
- Pulmonary vascular abnormalities contribute to management challenges in BPD.